19, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ... at the San Antonio Breast Cancer Symposium held December 14 – 29, 2019.
News
- Moleculin Announces New Data Shows Reversal of Tumor Activity in Animal Models
- AFAR & the Irene Diamond Fund provide $840000 to 2019 postdoctoral fellows studying aging
... Jia Nie, PhD, Postdoctoral Fellow, University of Texas Health at San Antonio, will study the Effect of Aging and ... that supports and advances pioneering biomedical research that is revolutionizing how we live healthier and longer.
- After SABCS stunner, Seattle Genetics nabs FDA breakthrough tag for tucatinib
Just a week after posting strong data at the San Antonio Breast Cancer Symposium, Seattle Genetics has nabbed the coveted FDA breakthrough label ...
- New animal model shows effective treatment for latent tuberculosis
San Antonio, Texas (December 17, 2019) - A major goal of tuberculosis (TB) ... Texas Biomed is one of the world's leading independent biomedical ...
- Adolfo Matamoros honored as SEI Fellow
Adolfo Matamoros, Ph.D., FACI, P.E, Peter T. Flawn Distinguished Professor in the UTSA Civil and Engineering Department has been elected as a ...